iotaMotion's Revolutionary U.S. Patent for Robotic Cochlear Implant Technology Unveiled
iotaMotion, Inc., a pioneering company specializing in robotic-assisted cochlear implant technologies, recently announced the official issuance of U.S. Patent No. 12,311,173. This critical development further cements iotaMotion's position as a leader in the field and supports its ambitious goal of advancing cochlear implant surgeries beyond current human capabilities.
The granted patent encompasses innovative systems designed to separate positioning and power components, thus improving the efficiency of robotically controlled positioning during surgeries. Mike Lobinsky, the CEO and President of iotaMotion, commented on the significance of this achievement, noting how it serves as a substantial milestone in their ongoing effort to enhance their intellectual property portfolio and expand their technology roadmap.
This announcement follows recent funding from the National Institutes of Health (NIH), which awarded two Phase I grants aimed at exploring further applications for robotic assistance in the cochlear implantation process. One of these grants was awarded to Qualia Oto, focused on evaluating robotic assistance for array insertion utilizing shape-changing polymers. The other grant supports iotaMotion's venture into developing a navigation-based insertion system designed to optimize the trajectory during the implantation process.
Expressing pride in the newly awarded patent, Costa Nikou, Chief Technology Officer at iotaMotion, emphasized the importance of this recognition in light of the company’s innovative approach within the clinical landscape. He stated, "This milestone reinforces the essential role of our technology in shaping the future of cochlear implantation and in advancing ongoing research and clinical practice."
iotaMotion's commitment to enhancing cochlear implantation strategies is further underscored by its collaborations with both academic institutions and industry partners. The future of cochlear implantation is looking promising, with expectations for integration of robotic assistance alongside navigation technologies and electrocochleography.
With the successful execution of hundreds of implant procedures using the iotaSOFT® Insertion System at over 25 centers across the United States, iotaMotion is focused on broadening its commercial reach while continuing to innovate its product lineup. The iotaSOFT® Insertion System is designed for a meticulously controlled electrode array insertion, aiming to safeguard vital intracochlear structures—a significant advancement in the field.
As iotaMotion, Inc. looks towards the future, its dedication to pushing the boundaries of surgical technology is evident. For more information on their cutting-edge solutions and ongoing projects, visit www.iotamotion.com or contact Wade Colburn, Vice President of Marketing and Clinical, at [email protected]
The granted patent encompasses innovative systems designed to separate positioning and power components, thus improving the efficiency of robotically controlled positioning during surgeries. Mike Lobinsky, the CEO and President of iotaMotion, commented on the significance of this achievement, noting how it serves as a substantial milestone in their ongoing effort to enhance their intellectual property portfolio and expand their technology roadmap.
This announcement follows recent funding from the National Institutes of Health (NIH), which awarded two Phase I grants aimed at exploring further applications for robotic assistance in the cochlear implantation process. One of these grants was awarded to Qualia Oto, focused on evaluating robotic assistance for array insertion utilizing shape-changing polymers. The other grant supports iotaMotion's venture into developing a navigation-based insertion system designed to optimize the trajectory during the implantation process.
Expressing pride in the newly awarded patent, Costa Nikou, Chief Technology Officer at iotaMotion, emphasized the importance of this recognition in light of the company’s innovative approach within the clinical landscape. He stated, "This milestone reinforces the essential role of our technology in shaping the future of cochlear implantation and in advancing ongoing research and clinical practice."
iotaMotion's commitment to enhancing cochlear implantation strategies is further underscored by its collaborations with both academic institutions and industry partners. The future of cochlear implantation is looking promising, with expectations for integration of robotic assistance alongside navigation technologies and electrocochleography.
With the successful execution of hundreds of implant procedures using the iotaSOFT® Insertion System at over 25 centers across the United States, iotaMotion is focused on broadening its commercial reach while continuing to innovate its product lineup. The iotaSOFT® Insertion System is designed for a meticulously controlled electrode array insertion, aiming to safeguard vital intracochlear structures—a significant advancement in the field.
As iotaMotion, Inc. looks towards the future, its dedication to pushing the boundaries of surgical technology is evident. For more information on their cutting-edge solutions and ongoing projects, visit www.iotamotion.com or contact Wade Colburn, Vice President of Marketing and Clinical, at [email protected]
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.